|
gptkbp:instanceOf
|
gptkb:insulin_formulation
|
|
gptkbp:administeredBy
|
short-acting insulin
|
|
gptkbp:alsoKnownAs
|
gptkb:Neutral_Protamine_Hagedorn_insulin
isophane insulin
|
|
gptkbp:appearance
|
cloudy suspension
|
|
gptkbp:ATCCode
|
A10AC01
|
|
gptkbp:contains
|
zinc
protamine
recombinant human insulin
|
|
gptkbp:discoveredBy
|
gptkb:Hans_Christian_Hagedorn
|
|
gptkbp:duration
|
12-18 hours
|
|
gptkbp:introducedIn
|
1946
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Novo_Nordisk
gptkb:Eli_Lilly_and_Company
gptkb:Sanofi
|
|
gptkbp:onset
|
1-2 hours
|
|
gptkbp:peakAction
|
4-12 hours
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
gptkb:lipodystrophy
gptkb:hypoglycemia
allergic reactions
|
|
gptkbp:storage
|
refrigeration recommended
|
|
gptkbp:typeOfInsulin
|
gptkb:intermediate-acting_insulin
|
|
gptkbp:usedFor
|
gptkb:diabetes_mellitus
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
included
|
|
gptkbp:bfsParent
|
gptkb:Hans_Christian_Hagedorn
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NPH insulin
|